Efficacy of a physical activity programme combining individualized aerobic exercise and coaching to improve physical fitness in neuromuscular diseases (I'M FINE): study protocol of a randomized controlled trial.
Active lifestyle
Aerobic exercise
Coaching
Motivational interviewing
Neuromuscular diseases
Physical fitness
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
13 May 2020
13 May 2020
Historique:
received:
04
03
2020
accepted:
12
04
2020
entrez:
15
5
2020
pubmed:
15
5
2020
medline:
23
9
2020
Statut:
epublish
Résumé
In individuals with neuromuscular diseases (NMD), symptoms of muscle weakness, fatigue and pain may limit physical activity. Inactivity leads to reduced physical fitness, which further complicates daily life functioning. Due to inconclusive evidence regarding exercise in NMD, the optimal training approach and strategies to preserve an active lifestyle remain to be determined. The physical activity programme I'M FINE, consisting of individualized aerobic exercise to improve physical fitness and coaching to preserve an active lifestyle, was therefore developed. The primary objective of this study will be to evaluate the efficacy of the I'M FINE programme in terms of improved physical fitness in individuals with slowly progressive NMD, compared to usual care. A multicentre, assessor-blinded, two armed, randomized controlled trial will be conducted in a sample of 90 individuals with slowly progressive NMD. Participants motivated to improve their reduced physical fitness will be randomized (ratio 1:1) to the I'M FINE intervention or usual care. The I'M FINE intervention consists of a six-month physical activity programme, including individualized home-based aerobic exercise to improve physical fitness (i.e. peak oxygen uptake), and motivational interviewing coaching (e.g. goal setting, self-management) to adopt and preserve an active lifestyle. Measurements will be performed at baseline, post-intervention, and at 12- and 18-months follow-up. The primary outcome is peak oxygen uptake (VO The I'M FINE study will provide evidence regarding the efficacy of a physical activity intervention on the physical fitness and active lifestyle over the short- and long-term in individuals with slowly progressive NMD. These outcomes could potentially improve the (inter)national guidelines for efficacy of aerobic exercise programmes and provide insight in achieving a more active lifestyle in NMD. (5/11/2018): Netherlands Trial Register NTR7609 (retrospectively registered), https://www.trialregister.nl/trial/7344. However, the Ethics Review Committee of the Amsterdam Medical Center (AMC) approved the study protocol on 7/11/2017. No adjustments were made to the approved study protocol before the first participant enrolment and registration. Registration was done after the second participant enrolment and the information in the register corresponds one on one with the approved study protocol.
Sections du résumé
BACKGROUND
BACKGROUND
In individuals with neuromuscular diseases (NMD), symptoms of muscle weakness, fatigue and pain may limit physical activity. Inactivity leads to reduced physical fitness, which further complicates daily life functioning. Due to inconclusive evidence regarding exercise in NMD, the optimal training approach and strategies to preserve an active lifestyle remain to be determined. The physical activity programme I'M FINE, consisting of individualized aerobic exercise to improve physical fitness and coaching to preserve an active lifestyle, was therefore developed. The primary objective of this study will be to evaluate the efficacy of the I'M FINE programme in terms of improved physical fitness in individuals with slowly progressive NMD, compared to usual care.
METHODS
METHODS
A multicentre, assessor-blinded, two armed, randomized controlled trial will be conducted in a sample of 90 individuals with slowly progressive NMD. Participants motivated to improve their reduced physical fitness will be randomized (ratio 1:1) to the I'M FINE intervention or usual care. The I'M FINE intervention consists of a six-month physical activity programme, including individualized home-based aerobic exercise to improve physical fitness (i.e. peak oxygen uptake), and motivational interviewing coaching (e.g. goal setting, self-management) to adopt and preserve an active lifestyle. Measurements will be performed at baseline, post-intervention, and at 12- and 18-months follow-up. The primary outcome is peak oxygen uptake (VO
DISCUSSION
CONCLUSIONS
The I'M FINE study will provide evidence regarding the efficacy of a physical activity intervention on the physical fitness and active lifestyle over the short- and long-term in individuals with slowly progressive NMD. These outcomes could potentially improve the (inter)national guidelines for efficacy of aerobic exercise programmes and provide insight in achieving a more active lifestyle in NMD.
TRIAL REGISTRATION
BACKGROUND
(5/11/2018): Netherlands Trial Register NTR7609 (retrospectively registered), https://www.trialregister.nl/trial/7344. However, the Ethics Review Committee of the Amsterdam Medical Center (AMC) approved the study protocol on 7/11/2017. No adjustments were made to the approved study protocol before the first participant enrolment and registration. Registration was done after the second participant enrolment and the information in the register corresponds one on one with the approved study protocol.
Identifiants
pubmed: 32404133
doi: 10.1186/s12883-020-01725-0
pii: 10.1186/s12883-020-01725-0
pmc: PMC7218829
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
184Subventions
Organisme : Prinses Beatrix Spierfonds
ID : W.OK17-03
Références
Br J Rheumatol. 1998 Feb;37(2):196-200
pubmed: 9569076
BMC Public Health. 2018 Oct 05;18(1):1160
pubmed: 30290793
Contemp Clin Trials. 2015 Jul;43:93-9
pubmed: 25962891
Clin Rehabil. 2014 Dec;28(12):1159-71
pubmed: 24942478
Res Q Exerc Sport. 1992 Mar;63(1):60-6
pubmed: 1574662
Medicine (Baltimore). 2016 Aug;95(31):e4497
pubmed: 27495097
Am J Phys Med Rehabil. 2002 Nov;81(11 Suppl):S108-20
pubmed: 12409816
Eur Respir J. 1997 Nov;10(11):2662-89
pubmed: 9426113
Scand J Rehabil Med. 1970;2(2):92-8
pubmed: 5523831
Brain. 2010 Oct;133(10):2838-44
pubmed: 20928945
Neurorehabil Neural Repair. 2016 Jun;30(5):402-10
pubmed: 26253175
Annu Rev Public Health. 2011;32:349-65
pubmed: 21128761
Neuromuscul Disord. 2007 Jun;17(6):459-69
pubmed: 17433675
Cochrane Database Syst Rev. 2019 Dec 6;12:CD003907
pubmed: 31808555
Neurology. 2019 Oct 29;93(18):e1720-e1731
pubmed: 31570565
Scand J Med Sci Sports. 2010 Oct;20 Suppl 2:1-10
pubmed: 20840557
J Rehabil Med. 2019 Jul 8;51(7):518-524
pubmed: 31243469
Arch Phys Med Rehabil. 2005 Jun;86(6):1155-63
pubmed: 15954054
Muscle Nerve. 2014 Jul;50(1):119-23
pubmed: 24639367
J Clin Epidemiol. 2007 Dec;60(12):1234-8
pubmed: 17998077
Arch Phys Med Rehabil. 2001 Dec;82(12):1678-85
pubmed: 11733882
Ann Phys Rehabil Med. 2013 Sep;56(6):420-33
pubmed: 23669143
Brain Behav. 2014 Jan;4(1):14-20
pubmed: 24653950
PM R. 2012 Nov;4(11):795-6
pubmed: 23174540
Respir Care. 2003 Aug;48(8):783-5
pubmed: 12890299
Phys Sportsmed. 2009 Oct;37(3):68-77
pubmed: 20048530
Arch Phys Med Rehabil. 2005 May;86(5):1030-6
pubmed: 15895353
Br J Sports Med. 2006 Mar;40(3):223-9
pubmed: 16505078
Neuromuscul Disord. 2009 Feb;19(2):99-103
pubmed: 19167889
J Clin Epidemiol. 1998 Nov;51(11):1055-68
pubmed: 9817123
Phys Med Rehabil Clin N Am. 2012 Aug;23(3):653-73
pubmed: 22938880
Muscle Nerve. 2013 Jul;48(1):3-20
pubmed: 23695822
PLoS One. 2016 Jan 11;11(1):e0146036
pubmed: 26751952
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
Am J Hosp Palliat Care. 2002 Jan-Feb;19(1):39-48
pubmed: 12173612
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Front Physiol. 2018 Sep 18;9:1287
pubmed: 30279663
Ann Readapt Med Phys. 2006 Jul;49(6):289-300, 375-84
pubmed: 16780988
Int J Behav Med. 2003;10(1):31-43
pubmed: 12581946
Arch Phys Med Rehabil. 2014 May;95(5):935-40
pubmed: 24491465
BMC Public Health. 2018 Sep 5;18(1):1097
pubmed: 30185171
Neurology. 2014 Nov 18;83(21):1914-22
pubmed: 25339206
Circulation. 2004 Jan 27;109(3):433-8
pubmed: 14744958
ESC Heart Fail. 2019 Aug;6(4):658-666
pubmed: 30963721
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Med Sci Sports Exerc. 2012 Oct;44(10):1993-2000
pubmed: 22617394
Disabil Rehabil. 2019 Jun;41(13):1584-1595
pubmed: 29409367
J Clin Neuromuscul Dis. 2009 Sep;11(1):7-21
pubmed: 19730017
J Subst Abuse Treat. 2016 Jun;65:36-42
pubmed: 26874558
Psychol Health. 2013 Nov;28(11):1265-86
pubmed: 23756082
Neurology. 2015 Aug 4;85(5):396-403
pubmed: 26156512